Neuronetics Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Financial Result and Cut Its FY24 Sales Guidance. Also, the Company Issued Q4 Sales Guidance Below Estimates.
Neuronetics Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Financial Result and Cut Its FY24 Sales Guidance. Also, the Company Issued Q4 Sales Guidance Below Estimates.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.